AK-1

N/A

Report date: 2024/01/19 15:04:02

Base Information

Drug NameAK-1
Drug Alias NameAK1Actokine-1
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsRadiation InjuriesNeoplasms +[3] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActoKine Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActoKine Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRadiation InjuriesNeoplasms +[3] 

Other Information

ATC CodeN/A
Related LinksN/A